pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,836 catalysts · 5,256 phase readout · 2,323 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 52 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×type: earnings×clear all
type
  • phase readout5,256
  • 8k filing2,323
  • pdufa321
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT05080946: Using Aspirin to Improve Immunological Features of Ovarian Tumors

Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: EARLY_PHASE1. Conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT04332146: Mindfulness-based Intervention for Postnatal Depression

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Postnatal Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT06254846: Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Uterine Cervical Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06671379: A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07100379: Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study

Sponsor: Boston Children's Hospital. Phase: NA. Conditions: Esophageal Atresia With Tracheo-esophageal Fistula, Esophageal Atresia, Esophageal Strictures

full page →ctgov ↗
›RECRUITINGphase readoutNCT06373679: Switch or Quit R01

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Cigarette Smoking, Smoking Behaviors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02697396: Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: HPV Vaccination

full page →ctgov ↗
›COMPLETEDphase readoutNCT07656662: Comparison of Split Box and Split Bone Block Techniques in Horizontal Ridge Augmentation

Sponsor: Marmara University. Phase: . Conditions: Horizontal Alveolar Ridge Deficiency

full page →ctgov ↗
›COMPLETEDphase readoutNCT04090762: Improving Perinatal Outcomes Using Conditional and Targeted Transfers

Sponsor: RAND. Phase: NA. Conditions: Utilization, Health Care, Birth Outcomes

full page →ctgov ↗
›COMPLETEDphase readoutNCT06723509: Description of Patient Adherence to Heart Failure Remote Monitoring and Its Determinants

Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: . Conditions: Remote Monitoring, Heart Failure Patients

full page →ctgov ↗
›COMPLETEDphase readoutNCT03222609: A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis

Sponsor: AbbVie. Phase: PHASE2. Conditions: Myelofibrosis (MF)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07653932: Perioperative Quantitative Sensory Testing and Incision Pain Mapping in Thoracic Surgery

Sponsor: Tongji Hospital. Phase: . Conditions: Postoperative Pain, Chronic Postsurgical Pain, Thoracic Surgery, Lung Resection, Mechanical Hyperalgesia, Central Sensitization

full page →ctgov ↗
›RECRUITINGphase readoutNCT07244263: A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

Sponsor: Takeda. Phase: PHASE2. Conditions: Hidradenitis Suppurativa

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05826379: Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife

Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Physical Inactivity, Walking, Cognitive Health, Self-regulation, Overweight and Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07687979: Mobile Application for Gait Training in Parkinson's Disease

Sponsor: Ege University. Phase: NA. Conditions: PARKINSON DIS

full page →ctgov ↗
›RECRUITINGphase readoutNCT07128446: COPM-Based Goal Setting Strategies in the PICU

Sponsor: Samsung Medical Center. Phase: NA. Conditions: Critical Illness, Pediatric Intensive Care Unit

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07709546: Closed Incision NPWT to Prevent Wound Complications Post-ECMO

Sponsor: St. Antonius Hospital. Phase: NA. Conditions: ExtraCorporeal Membrane Oxygenation (ECMO), Wound Complications, Surgical Site Infection (SSI)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06540079: BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

Sponsor: Biotronik, Inc.. Phase: NA. Conditions: Sinus Node Dysfunction, Bradycardia, Atrioventricular Block

full page →ctgov ↗
›RECRUITINGphase readoutNCT07395479: A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: EARLY_PHASE1. Conditions: Advanced Malignant Tumours

full page →ctgov ↗
›RECRUITINGphase readoutNCT06386796: Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients

Sponsor: Aswan University. Phase: . Conditions: Acute Kidney Injury, Critical Illness

full page →ctgov ↗
›TERMINATEDphase readoutNCT06702579: Home Monitoring in Hemophilia A

Sponsor: Radboud University Medical Center. Phase: . Conditions: Hemophilia A, Anticoagulant Therapy, Monitoring, Point of Care Testing, Qualitative Research

full page →ctgov ↗
›RECRUITINGphase readoutNCT05067179: Analysis of Human ALS Tissues and Registry of ALS Patients

Sponsor: University of Illinois at Chicago. Phase: . Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05318196: Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Sponsor: University Hospital, Toulouse. Phase: . Conditions: Acute Kidney Injury, Chronic Kidney Diseases, Solid-organ Transplantation, Cancer, Metabolic Disease, Immune Diseases

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07274579: An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma

Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Digestive Oncology

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05212428: DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study

Sponsor: Mayo Clinic. Phase: NA. Conditions: Genetic Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07310628: Comparison of Analgesic Efficacy of Intrathecal Levobupivacaine With and Without Oral Tizanidine in Lower Limb Surgeries: A Prospective Randomized Study

Sponsor: All India Institute of Medical Sciences. Phase: PHASE4. Conditions: Tizanididne, Levobupicaine, Lower Limb Surgery, Pain, Chronic

full page →ctgov ↗
›COMPLETEDphase readoutNCT04052828: Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)

Sponsor: Dr Erin Perrone. Phase: NA. Conditions: Congenital Diaphragmatic Hernia

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07250828: Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy

Sponsor: TriCity Research Center. Phase: NA. Conditions: Painful Diabetic Neuropathy (PDN), Diabetic Neuropathy, Neuropathic Pain, Chronic Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05094128: A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting

Sponsor: AbbVie. Phase: . Conditions: Axial Spondylarthritis (r-axSpA)

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05118867: Improve the Patients' Recovery With Family- Caregivers to End Delirium

Sponsor: Mayo Clinic. Phase: NA. Conditions: Delirium

full page →ctgov ↗
›RECRUITINGphase readoutNCT07490600: Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment of Cocaine Use Disorder

Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Cocaine Use Disorder (CUD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05140200: Study of GSK3511294 in Healthy Chinese Participants

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07088107: A Neurofeedback Interface in Poststroke Neuromodulation Using TMS-fNIRS

Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07105800: Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment

Sponsor: Taipei Medical University Shuang Ho Hospital. Phase: NA. Conditions: Older Adults, Cognitive Impairment, Mild

full page →ctgov ↗
›RECRUITINGphase readoutNCT06547736: Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Sponsor: Fudan University. Phase: PHASE2. Conditions: Pancreatic Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT02812134: Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition.

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Malnutrition

full page →ctgov ↗
›COMPLETEDphase readoutNCT02692664: Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft

Sponsor: JOTEC GmbH. Phase: . Conditions: Iliac Aneurysm, AAA

full page →ctgov ↗
›RECRUITINGphase readoutNCT07578909: Retro Walking With and Without Bosu Ball for Balance and Mobility in Hearing Impaired Children

Sponsor: Riphah International University. Phase: NA. Conditions: Hearing Impaired Children

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06155409: Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease

Sponsor: SPINEVISION SAS. Phase: . Conditions: Intervertebral Disc Degeneration

full page →ctgov ↗
›RECRUITINGphase readoutNCT06203899: Depression and Suicide Prevention in Adolescents Attending Special Schools

Sponsor: Ggz Oost Brabant. Phase: NA. Conditions: Depressive Symptoms

full page →ctgov ↗
›COMPLETEDphase readoutNCT05160532: Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Knee Osteoarthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04673032: Radiofrequency (RF) Ablation Prospective Outcomes Study

Sponsor: Boston Scientific Corporation. Phase: . Conditions: Pain, Chronic

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05717998: Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: . Conditions: Lung Non-Small Cell Carcinoma, GastroEsophageal Cancer, Esophagus Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05714163: Effects of Ai Chi on Scapular Muscle Activation in Overhead Athletes With Scapular Dyskinesis

Sponsor: National Taiwan University Hospital. Phase: . Conditions: Scapular Dyskinesis, Athletic Injuries, Muscle Weakness, Overuse Injury

full page →ctgov ↗
›TERMINATEDphase readoutNCT03420963: Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm, Recurrent Malignant Male Reproductive System Neoplasm, Recurrent Malignant Mesothelioma, Recurrent Malignant Neoplasm of Multiple Primary Sites, Recurrent Malignant Oral Neoplasm, Recurrent Malignant Pharyngeal Neoplasm, Recurrent Malignant Skin Neoplasm, Recurrent Malignant Soft Tissue Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Malignant Thyroid Gland Neoplasm, Recurrent Malignant Urinary System Neoplasm, Refractory Cutaneous Melanoma, Refractory Malignant Bone Neoplasm, Refractory Malignant Endocrine Neoplasm, Refractory Malignant Female Reproductive System Neoplasm, Refractory Malignant Male Reproductive System Neoplasm, Refractory Malignant Mesothelioma, Refractory Malignant Neoplasm of Multiple Primary Sites, Refractory Malignant Oral Neoplasm, Refractory Malignant Pharyngeal Neoplasm, Refractory Malignant Skin Neoplasm, Refractory Malignant Soft Tissue Neoplasm, Refractory Malignant Solid Neoplasm, Refractory Malignant Thyroid Gland Neoplasm, Refractory Malignant Urinary System Neoplasm

full page →ctgov ↗
›WITHHELDphase readoutNCT06853093: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT06638463: My Health Coach App RCT

Sponsor: University of Rochester. Phase: NA. Conditions: Fetal Alcohol Spectrum Disorders

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05220163: Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19

Sponsor: University of Cape Town. Phase: NA. Conditions: Tuberculosis, COVID-19, HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT06712563: Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

Sponsor: AstraZeneca. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05852587: Xylitol Use for Decolonization of C. Difficile in Patients With IBD

Sponsor: Brigham and Women's Hospital. Phase: PHASE1. Conditions: Inflammatory Bowel Diseases, Clostridioides Difficile Infection

full page →ctgov ↗
← prev
page 102 of 117
next →